Physician profile
Mark Page Miller
NPI 1265490718
$15,058.25
in general payments reported to CMS, 2019-2025
12 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $79.80 · 2021: $10K · 2022: $542 · 2023: $535 · 2024: $2,736 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224 · Travel and Lodging: $1,180 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.36 |
| Travel and Lodging | $1,179.85 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,406.58 | 2019-2023 | Da Vinci Surgical System |
| Biotissue Holdings INC. | $2,142.92 | 2022-2024 | |
| Medtronic, INC. | $1,000.00 | 2024 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| Asensus Surgical, INC. | $150.01 | 2019 | |
| Karl Storz Endoscopy-America | $110.34 | 2025 | Image 1 S |
| Acell, INC. | $108.16 | 2019-2020 | |
| Davol INC. | $33.35 | 2024 | Phasix Mesh |
| Ethicon US, LLC | $27.57 | 2022 | |
| Smith+Nephew, INC. | $23.03 | 2025 | Stravix Pl, Grafix Pl |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.13 | 2019 | |
| Shire North American Group INC | $20.56 | 2019 | |
| Merz North America, INC. | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.